Innoblative is a private medical device company addressing clinical unmet needs for patients with breast cancer and other soft tissue diseases. We are developing advanced energy-based surgical solutions to help improve the way surgeons coagulate and ablate soft tissue to achieve better care for patients. Innoblative has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the company’s SIRA® RFA Electrosurgical Device.
The SIRA® device is investigational for use in BCS and is not yet available for sale in the United States.
The SIRA® device is cleared for intraoperative coagulation and ablation of soft tissue.
Company Details
- Employees
- 12
- Founded
- -
- Address
- 965 W Chicago Ave, Chicago,illinois 60642,united States
- in****@****ive.com
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://www.innoblative.com
- HQ
- Chicago, Illinois
Innoblative Questions
Innoblative's website is http://www.innoblative.com
Innoblative's LinkedIn profile is https://www.linkedin.com/company/innoblative
Innoblative has
12 employees.
View email and phone details for 12
employees at Innoblative.
Innoblative's industry is
Medical Equipment Manufacturing
Innoblative's top competitors are
Kandu,
Edge Surgical, Inc.,
Madison Scientific Inc,
Puzzle Medical Devices® Inc.,
Nuvo Cares,
Ventris Medical,
Lumicell,
Brainomix,
Proprio,
Cardiovia.
Innoblative's support email address is info@innoblative.com
Innoblative's categories are Medical Equipment Manufacturing
Innoblative's founding year is 2013
